Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F.
Falchi-Carvalho M, et al. Among authors: laborde s.
Eur Neuropsychopharmacol. 2024 Mar;80:27-35. doi: 10.1016/j.euroneuro.2023.12.006. Epub 2023 Dec 22.
Eur Neuropsychopharmacol. 2024.
PMID: 38141403
Clinical Trial.